Scientist Paul Greengard has discovered a hopefully, major breakthrough with an alzheimer's drug. He has discovered a new protein needed to make beta amyloid. Beta Amyloid is a plaque build up in the brain of alzheimer patients. The new finding reveals a drug target that could slow down the affects of alzheimers on the brain.
Greengard became interested in researching a cure for alzheimer's after his father in law was diagnosed with the disease 25 years ago. His research has been funded by federal grants and funds.
To view the whole article visit http://www.nytimes.com/2010/09/02/health/research/02alzheimer.html